'Wake Up and Smell the Cannabis': Harborside Health Center

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
'Wake Up and Smell the Cannabis': Harborside Health Center co-founder Steve DeAngelo releases statement on passage of Hinchey-Rohrabacher Amendment by U.S. House

OAKLAND, CALIF., May 30, 2014 (GLOBE NEWSWIRE) -- On Thursday, May 29, the U.S. House of Representatives passed the Hinchey-Rohrabacher medical marijuana amendment, prohibiting the U.S. Department of Justice and the Drug Enforcement Administration (DEA) from appropriating funds to raid, arrest or prosecute medical marijuana patients and providers in states where medical marijuana is legal. Today, long-time activist, co-founder and executive director of Harborside Health Center—the nation's largest, state-legal, model nonprofit medical cannabis dispensary—Steve DeAngelo, releases the following statement on this monumental decision:

"Message to elected officials and candidates everywhere: the passage of the Hinchey-Rohrabacher Amendment by the U.S. House of Representatives was no accident. In fact, Hinchey-Rohrabacher has been one of the central goals of the medical cannabis movement for almost 20 years, and its passage is a clear sign of our movement's growing political sophistication and potency. Prohibitionists who predicted 'the stoners' would just lose motivation and forget about it have been proven decisively wrong. With public opinion polls showing overwhelming bipartisan support for medical cannabis nationwide, and some sort of medical cannabis laws passed in half the states—even Florida and Georgia—those politicians feckless enough to resist the tide are rapidly running out of places to hide.

"Of course, Hinchey-Rohrabacher will not become law unless and until the Senate passes it, and the President signs the appropriations measure to which it is attached. Regardless, it is now time for the functionaries of our democracy to wake up and smell the cannabis.

"In the United States, we invest public servants with some degree of discretion, to ensure that our laws are administered consistently with our social consensus and sense of justice. Public employees whose personal views prevent them from implementing the new public consensus on cannabis should either set aside those views, modify them, or find new jobs—perhaps in the rapidly shrinking ranks of professional anti-cannabis advocates.

"Anti-scientific bureaucrats like DEA Administrator Michele Leonhart, who can't tell the difference between heroin and cannabis, should either take some lessons at Oaksterdam University, or do the decent thing and resign. U.S. attorneys—like Melinda Haag in the Northern District of California, and Ben Wagner in the Eastern District of California—who continue to prosecute state-legal medical cannabis providers, should either drop those actions or be fired by the attorney general of the United States for insubordination.

"The latest outrageous flouting of state law, this time by the U.S. Attorney Michael Ormsby for the Eastern District of Washington, shows the real world damage caused by these out-of-control ideologues. Ormsby is prosecuting Larry Harvey, a 70-year-old retired truck driver and state-legal medical cannabis patient, on federal cannabis charges. Harvey, three family members and a friend (now know as the 'Kettle Falls 5') were growing 70 cannabis plants to medicate a variety of ailments including gout, osteoarthritis, wasting syndrome, and chronic pain from severe back injuries.

"All five had legally valid written recommendations from their doctors, and were growing and using cannabis in accordance with Washington's medical cannabis law. Now all five are facing sentences of 10 years to life, because Michael Ormsby has decided to ignore both state cannabis law and overwhelming public support for medical cannabis.

"It is well past time for this sort of nonsense to end. American democracy provides citizens the ability to change laws, and remove elected officials who flout our will. But lacking a more direct mechanism, we citizens depend on those same elected officials to supervise and control the public servants who actually administer justice.

"Recent election wins, overwhelmingly supportive public opinion polls, a tsunami of state medical cannabis laws, and the passage of Hinchey-Rohrabacher make it crystal clear: it's time for our elected representatives to reign in the out-of-control federal drug bureaucracy. Those elected officials who fail to take action do so at their own peril. Contrary to myth, cannabis consumers have very good long-term memories and staying power. The long sought passage of Hinchey-Rohrabacher proves it."

About Harborside Health Center:

Founded by national cannabis leader, Steve DeAngelo , in 2006, Harborside Health Center is the nation's largest, not-for-profit, model medical cannabis dispensary. The San Jose and Oakland medicinal cannabis collective offers its 130,000 registered patients free holistic healing services, lab-tested medicine and education. Harborside was featured on the Discovery Channel miniseries, "Weed Wars," in December 2011 (now streaming on Netflix), on the premiere episode of CNN's "Inside Man," hosted by Morgan Spurlock in June 2013, and in Fortune Magazine 's cover story, "Yes We Cannabis," in April 2013. DeAngelo also co-founded the nation's first cannabis-testing facility, Steep Hill Lab, and the country's first cannabis investment firm, The ArcView Group. "Out of the shadows and into the light" epitomizes DeAngelo's mission to enlighten the public on the many medicinal and therapeutic benefits of the cannabis plant and actively works to empower the country to change its image of medical marijuana.

Gaynell Rogers 415-298-1114 Samantha Campos 510-388-4991

Scroll down for more posts ▼

Top 10 Most Recent News Articles

MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 14

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading

Top 5 Most Recently Viewed Articles

You Call The Play Inc. (YCTP) Leads with Integrity in Betting

Updated Category News Views 154

Understanding You Call The Play Inc. (YCTP)'s Initiative In an important move for the sports betting landscape, You Call The Play Inc. (YCTP) has recently unveiled a national licensing plan and a groundbreaking measure called the Safe Bet Overlay™. This initiative is designed to foster trust and transparency within an industry that continues to grow rapidly across the...

Continue Reading
Cash for Houses Pro Earns Stellar Reputation with 5-Star Reviews

Updated Category News Views 167

Cash for Houses Pro Achieves 5-Star Reviews Cash for Houses Pro is celebrating their recent success in receiving numerous 5-star reviews on Google for their service known as 'Sell Your House Fast In Tampa FL For Cash'. This recognition reflects the team's dedication to providing homeowners with a seamless and stress-free home selling experience. About Cash for Houses Pro...

Continue Reading
Pfizer's Potential Transformation Following Starboard Investment

Updated Category News Views 77

Pfizer's Revised Price Target and Market Standing Recently, CFRA, a prominent financial research firm, elevated its price target for Pfizer Inc. (NYSE:PFE) from $30.00 to $31.00 per share. This adjustment comes while maintaining a 'Hold' rating on the stock, suggesting a careful observation of its market performance. The current price target reflects a valuation based on...

Continue Reading
Equinox Gold's Impressive Q2 Results Spark Stock Surge Today

Updated Category News Views 103

Equinox Gold Delivers Strong Quarterly Performance Equinox Gold Corp. EQX has seen its shares rise significantly following the release of its second-quarter financial results, which exceeded market expectations. Investors reacted favorably, driving the stock up on Thursday. Financial Highlights from the Quarter In the latest quarterly report, Equinox Gold announced...

Continue Reading
Investor Insights on Alexandria Real Estate Equities' Legal Challenges

Updated Category News Views 219

Understanding the Alexandria Real Estate Equities, Inc. Lawsuit Investors have an important opportunity arising from a lawsuit against Alexandria Real Estate Equities, Inc. (NYSE: ARE). A national shareholder rights litigation firm has initiated a class action alleging the Company has violated various securities laws. This situation has caught the attention of many...

Continue Reading